Patents Prosecuted
| Application number | Title of the patent | IPC | Filing Date | Decision Date |
|---|---|---|---|---|
| 18308526 | METHODS TO ESTIMATE EFFECTIVENESS OF A MEDICAL TREATMENT | G06N, G16H, A61B, G06F | Apr 26, 2023 | |
| 18305751 | Medicament Delivery Device | A61N, A61M | Apr 23, 2023 | |
| 18304519 | Compositions and Methods for Treating Spinal Muscular Atrophy | A61K | Apr 20, 2023 | |
| 18303353 | MODIFIED BINDING POLYPEPTIDES FOR OPTIMIZED DRUG CONJUGATION | C07K, A61K | Apr 18, 2023 | |
| 18302759 | SYSTEMS AND METHODS FOR CONTROLLING OXYGEN LEVELS | G01R, G01N | Apr 17, 2023 | |
| 18300834 | ANTI-CD38 ANTIBODIES AND FORMULATIONS | A61K, C07K | Apr 13, 2023 | |
| 18299656 | DENDRITIC CELL ASSAY FOR INNATE IMMUNOGENICITY TO GENE THERAPY AGENTS | C12N, A61K | Apr 11, 2023 | |
| 18299632 | USE OF IRAK4 MODULATORS FOR GENE THERAPY | A61K | Apr 11, 2023 | |
| 18299640 | USE OF AN IRAK4 MODULATOR FOR GENE THERAPY | C12N, C07K, A61K | Apr 11, 2023 | |
| 18297133 | CONTAINER FOR AN INJECTABLE MEDICAMENT | A61M | Apr 6, 2023 | |
| 18296088 | Drug Delivery Device | A61M | Apr 4, 2023 | |
| 18188176 | ANALYTICAL ULTRACENTRIFUGATION FOR CHARACTERIZATION OF RECOMBINANT VIRAL PARTICLES | C12N, G01N | Mar 21, 2023 | |
| 18186731 | Pharmaceutical Recombinant Human Acid Sphingomyelinase Compositions and Methods | B01D, C12N, A61P | Mar 19, 2023 | |
| 18183107 | TRISPECIFIC BINDING PROTEINS, METHODS, AND USES THEREOF | C07K, C12N, A61P | Mar 12, 2023 | |
| 18119201 | GENE THERAPY FOR NIEMANN-PICK DISEASE TYPE A | C12N, A61K | Mar 7, 2023 | |
| 18179890 | Residual semi-recurrent neural networks | G06N, G01N | Mar 6, 2023 | May 6, 2024 |
| 18178692 | SYSTEM AND METHOD FOR SUPPORTING ON THE USE OF AN INJECTION DEVICE | G16H | Mar 5, 2023 | |
| 18174575 | METHODS OF PROCESSING A FLUID | C07K, B01D | Feb 23, 2023 | |
| 18174582 | DRIVE MECHANISM FOR AN INJECTION DEVICE | A61M | Feb 23, 2023 | |
| 18172294 | Acoustic detection of a usage of an injection device | G01F, A61M | Feb 20, 2023 | May 13, 2024 |